Keywords:
холестатический синдром, дети, гепато–билиарная система, клиника, симптомы.References
Буеверов А. О. Холестатические аутоиммунные заболевания печени // Лечебное дело. 2014. №2. URL: https://cyberleninka.ru/article/ n/holestaticheskie–autoimmunnye–zabolevaniya–pecheni
Буеверов А.О. Возможности клинического применения урсодезоксихолевой кислоты // Consilium medicum. – 2015. – Т. 7, № 6. – С. 28–34.
Губергриц Н.Б. Внутрипеченочный холестаз. Этиология, патогенез, клиника, диагностика, лечение // Сучасна гастроентерологія. – 2013. – № 2. – С. 13–18.
Дегтярева И.И., Скрыпник И.Н., Невойт А.В. и соавт. Гепатопротекторы–антиоксиданты в терапии больных с хроническими диффузными заболеваниями печени // Новые медицинские технологии. – 2022. – № 6. – С. 18–23.
Corpechot C., Carrat F., Poupon R.E. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol–treated patients // Gastroenterology. 2018. V. 122. P. 652–658.
Eleonora Druve Tavares Priamry sclerosing cholangitis in children and adolescents // Arq. Gastroenterol. — 2017. — Vol. 54. — №.4.
El–Guindi MA, Sira MM, Sira AM, Salem TA, El–Abd OL, Konsowa HA, El–Azab DS, Allam AA. Design and validation of a diagnostic score for biliary atresia. Journal of hepatology 2014; 61(1): 116–23.
Frongillo F, Bianco G, Silvestrini N. Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review. Transplant Proc. 2015 Sep;47(7):2179–81.
Gupta DK, Srinivas M, Bajpai M. AIIMS clinical score: a reliable aid to distinguish neonatal hepatitis from extra hepatic biliary atresia. Indian journal of pediatrics 2021; 68(7): 605–8.
Hartley J, Harnden A, Kelly D. Biliary atresia. BMJ 2020;340: c2383.
Hwa Pyung Lee, Ben Kang, So Yoon Choi, Sanghoon Lee, Suk–Koo Lee, Yon Ho Choe. Outcome of Alagille Syndrome Patients Who Had Previously Received Kasai Operation during Infancy: A Single Center Study. Pediatr Gastroenterol Hepatol Nutr. – 2015 Sep. 18(3): 175–179.
Jagadisan B., Srivastava A. Child with Jaundice and Pruritus: How to Evaluate?// Indian J Pediatr. — 2016. — 83(11). — P. 1311–1320.
Larazidis K.N., Gores G.J., Lindor K.D. Ursodeoxycholic acid «mechanisms of action and clinical use in hepatobiliary disorders» // J. Hepatology. – 2021. – Vol. 35. – P. 134–136.
Ling S.C. Сongenital cholestatic syndromes: what happens when children grow up // Can J Gastroenterol. — 2017. — Vol. 21 (11). — P. 743–751.
Mieli–Vergani G, Vergani D. Biliary atresia. Semin Immunopathol 2019; 31(3): 371–81.
Moyer V., Freese D.K., Whitington P.F., Olson A.D. et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition // J Pediatr Gastroenterol Nutr. — 2014. — Vol. 39 (2). — P. 115–128.
Paumgarther G., Beuers U. Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited // Hepatology. – 2022. – Vol. 36. – P. 525–531.
Perez MJ, Briz O. Bile acid–induced cell injury and protection, World J Gastroenterology 2019, 15(14):11677–1689.
Russo P, Magee JC, Boitnott J, Bove KE, Raghunathan T, Finegold M, Haas J, Jaff e R, Kim GE, Magid M, Melin–Aldana H, White F, Whitington PF, Sokol RJ. Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy. Clin Gastroenterol Hepatol. – 2021; 9:357–62e2.
Tiao MM, Tsai SS, Kuo HW, Chen CL, Yang CY. Epidemiological features of biliary atresia in Taiwan, a national study 2006–2013. Journal of gastroenterology and hepatology 2018; 23(1): 62–6.
Wang W. Studies of virus and immune system responses in biliary atresia / W. Wang, S. Zheng // Int. J. Pediatr. — 2016. — Vol. 33. — P. 270–271.
Yang JG, Ma DQ, Peng Y, Song L, Li CL. Comparison of diff erent diagnostic methods for diff erentiating biliary atresia from idiopathic neonatal hepatitis. Clin Imaging 2019; 33:439–46.